Gabor Gyulveszi

Gabor Gyulveszi has extensive experience in the biotechnology and pharmaceutical industries. Gabor is currently serving as the Chief Business Officer at Rejuveron Life Sciences AG. Prior to this role, they held positions as a Board Observer at Exo Therapeutics, Boundless Bio, and C4 Therapeutics, Inc. Gabor also worked as a Senior Associate at Nextech Invest. Earlier in their career, they were employed by Roche, where they held various scientific positions, including Principal Scientist, Senior Scientist, and Scientist. Gabor began their career as a Postdoctoral Researcher at the Institute for Research in Biomedicine. Gabor Gyulveszi has a strong background in research, as well as business and investment strategies in the life sciences sector.

Gabor Gyulveszi completed their Master's degree in Molecular Biology and Genetics from the University of Szeged, from the year 2000 to 2005. Following that, they pursued a Doctor of Philosophy (PhD) degree in Experimental Immunology at the University of Zurich from 2006 to 2010.